Kai S, Kohmura H, Ishikawa K, Kawano S, Sakai A, Kuroyanagi K, Kadota T, Takahashi N
Preclinical Research Laboratories, Bristol-Myers Squibb K. K.
Jpn J Antibiot. 1992 Jun;45(6):642-60.
Cefepime dihydrochloride (CFPM) was administered subcutaneously daily at doses of 0, 150, 500 and 1,000 mg/kg for 63 days prior to mating and during mating to male Crj: CD (SD) rats and for 14 days prior to mating and during mating, as well as periods of gestation and lactation to female SD rats. Saline and L-arginine hydrochloride (L-arginine) were used as control articles. Daily doses of test and control articles were equally divided and administered twice a day (b.i.d.). The results obtained are summarized as follows: 1. Soft stool was observed for both male and female F0 rats at CFPM 1,000 mg/kg at the first week of administration period. Further, depilation of injection sites was found in 7 males and 12 females at the same dose level. 2. Body weight gains were suppressed in male F0 rats from Day 28 to 63 of administration period at CFPM 1,000 mg/kg. Moreover, food consumption was reduced in F0 female rats during the first week of administration period at all dose levels of CFPM. 3. CFPM failed to affect the reproductive performance in both male and female F0 rats. 4. Kidney weights were increased in both male and female F0 rats and adrenal weights were augmented in male F0 rats at CFPM 1,000 mg/kg. On the other hand, cecal enlargement were observed for F0 dams treated with CFPM. However, these changes were not considered to be unique to this drug, because they have been described with most antibiotics in this species and appears to be results of modifications in gut flora. 5. Prenatal developments in F1 fetuses were not affected by CFPM. 6. CFPM failed to affect delivery status of F0 dams or survival and lactation indices in F1 pups. 7. CFPM did not affect postnatal differentiations, developmental behaviors, learning ability and memory, spontaneous motor activity or emotionality in F1 rats. 8. Body weight gains and food consumption in both male and female F1 rats were not affected by CFPM. 9. CFPM did not alter the organ weights in both male and female F1 rats. 10. There were no significant differences between drug treated animals and controls regarding the reproductive performance and delivery status of F1 rats. 11. Influences on survival indices, body weights and organ weights were not apparently observed for F2 pups even at CFPM 1,000 mg/kg. Based on the reproductive and developmental indices, the no-effect dose level of CFPM under the present experimental condition was estimated to be 1,000 mg/kg/day against dams (F0) and their offspring (F1).
在交配前及交配期间,对雄性Crj:CD(SD)大鼠每日皮下注射盐酸头孢吡肟(CFPM),剂量分别为0、150、500和1000mg/kg,持续63天;对雌性SD大鼠在交配前及交配期间、妊娠期和哺乳期每日皮下注射CFPM,持续14天。以生理盐水和盐酸L-精氨酸(L-精氨酸)作为对照品。受试品和对照品的每日剂量均分为两份,每天给药两次(bid)。所得结果总结如下:1. 在给药期第一周,CFPM剂量为1000mg/kg时,雌雄F0代大鼠均出现软便。此外,在相同剂量水平下,发现7只雄性和12只雌性大鼠注射部位脱毛。2. 在给药期第28天至63天,CFPM剂量为1000mg/kg时,雄性F0代大鼠体重增加受到抑制。此外,在CFPM所有剂量水平下,F0代雌性大鼠在给药期第一周食物摄入量减少。3. CFPM对雌雄F0代大鼠的生殖性能均无影响。4. CFPM剂量为1000mg/kg时,雌雄F0代大鼠肾脏重量增加,雄性F0代大鼠肾上腺重量增加。另一方面,用CFPM处理的F0代母鼠出现盲肠肿大。然而,这些变化不被认为是该药物特有的,因为在该物种中大多数抗生素都有这种情况描述,似乎是肠道菌群改变的结果。5. CFPM对F1代胎儿的产前发育无影响。6. CFPM对F0代母鼠的分娩情况或F1代幼崽的存活及哺乳指数无影响。7. CFPM对F1代大鼠的产后分化、发育行为、学习能力和记忆、自发运动活动或情绪无影响。8. CFPM对雌雄F1代大鼠的体重增加和食物摄入量无影响。9. CFPM未改变雌雄F1代大鼠的器官重量。10. 在F1代大鼠的生殖性能和分娩情况方面,药物处理组动物与对照组之间无显著差异。11. 即使CFPM剂量为1000mg/kg,F2代幼崽的存活指数、体重和器官重量也未观察到明显影响。根据生殖和发育指标,在本实验条件下,CFPM对母鼠(F0)及其后代(F1)的无作用剂量水平估计为1000mg/kg/天。